Lexeo Therapeutics, Inc. (LXEO)
4.07
-0.13
(-3.10%)
USD |
NASDAQ |
Sep 21, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Lexeo Therapeutics Price : 4.07 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 4.16 | 4.225 | 4.059 | 4.20 | 2.288M |
| Sep 17, 2026 | 4.27 | 4.38 | 4.14 | 4.18 | 1.099M |
| Sep 16, 2026 | 4.16 | 4.22 | 4.09 | 4.16 | 619511.0 |
| Sep 15, 2026 | 4.18 | 4.275 | 4.01 | 4.13 | 888402.0 |
| Sep 14, 2026 | 4.31 | 4.36 | 4.18 | 4.21 | 1.264M |
| Sep 11, 2026 | 4.43 | 4.475 | 4.205 | 4.25 | 1.491M |
| Sep 10, 2026 | 4.43 | 4.44 | 4.31 | 4.36 | 420870.0 |
| Sep 09, 2026 | 4.72 | 4.805 | 4.48 | 4.48 | 311687.0 |
| Sep 08, 2026 | 4.82 | 4.87 | 4.66 | 4.76 | 357808.0 |
| Sep 04, 2026 | 4.76 | 4.99 | 4.76 | 4.89 | 296442.0 |
| Sep 03, 2026 | 4.80 | 4.92 | 4.67 | 4.84 | 313344.0 |
| Sep 02, 2026 | 4.76 | 4.96 | 4.65 | 4.78 | 468357.0 |
| Sep 01, 2026 | 4.70 | 4.77 | 4.564 | 4.70 | 420477.0 |
| Aug 31, 2026 | 4.82 | 4.82 | 4.62 | 4.76 | 472038.0 |
| Aug 28, 2026 | 4.96 | 4.96 | 4.73 | 4.86 | 663607.0 |
| Aug 27, 2026 | 4.97 | 5.09 | 4.885 | 4.99 | 1.106M |
| Aug 26, 2026 | 5.10 | 5.11 | 4.91 | 5.01 | 689958.0 |
| Aug 25, 2026 | 4.97 | 5.13 | 4.94 | 5.13 | 937385.0 |
| Aug 24, 2026 | 4.88 | 4.965 | 4.70 | 4.92 | 518496.0 |
| Aug 21, 2026 | 5.12 | 5.204 | 4.84 | 4.88 | 509587.0 |
| Aug 20, 2026 | 5.29 | 5.355 | 4.90 | 5.06 | 1.114M |
| Aug 19, 2026 | 5.07 | 5.405 | 5.05 | 5.37 | 941950.0 |
| Aug 18, 2026 | 4.94 | 5.05 | 4.825 | 4.93 | 649791.0 |
| Aug 17, 2026 | 4.83 | 5.026 | 4.82 | 4.98 | 913839.0 |
| Aug 14, 2026 | 4.98 | 4.98 | 4.72 | 4.84 | 676670.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 68.80 |
| Oncolytics Biotech, Inc. | 0.7679 |
| Sangamo Therapeutics, Inc. | 0.1449 |
| Sarepta Therapeutics, Inc. | 20.13 |
| Anixa Biosciences, Inc. | 2.70 |
Price Related Metrics
| Price to Book Value | 1.361 |
| Earnings Yield | -28.44% |
| Market Cap | 319.99M |